NCT00724841 2016-07-22A Phase I/II Study of GMX1777 in Combination With Temozolomide for the Treatment of Metastatic MelanomaTeva Branded Pharmaceutical Products R&D, Inc.Phase 1/2 Terminated1 enrolled